ABBOTT LABORATORIES — Director's Dealing 2007

Aug 25, 2007

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2007-08-22

Reporting Person: Tyree James L (Senior Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2007-08-22	Common shares without par value	M	10276	$40.9283	Acquired	112928	Direct
2007-08-22	Common shares without par value	M	7493	$41.5392	Acquired	120421	Direct
2007-08-22	Common shares without par value	M	6122	$41.0317	Acquired	126543	Direct
2007-08-22	Common shares without par value	F	20584	$52.36	Disposed	105959	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2007-08-22	Option (right to buy)	$40.9283	M	10276	Disposed	2010-02-10	Common shares (10276)	Direct
2007-08-22	Option (right to buy)	$41.5392	M	7493	Disposed	2010-02-10	Common shares (7493)	Direct
2007-08-22	Option (right to buy)	$41.0317	M	6122	Disposed	2014-02-19	Common shares (6122)	Direct
2007-08-22	Option (right to buy)	$52.36	A	15473	Acquired	2010-02-10	Common shares (15473)	Direct
2007-08-22	Option (right to buy)	$52.36	A	5111	Acquired	2014-02-19	Common shares (5111)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common shares without par value	1155	Indirect

Footnotes

F1: Balance in the Abbott Laboratories Stock Retirement Trust as of August 22, 2007.

F2: Employee stock option including a replacement option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.